Richard Chesworth

USPTO Granted Patents = 107 (Patent Applications = 57)

CIPO Patents = 9 (Patent Applications = 13)

EPO Patents = 38 (Patent Applications = 56)

Average Co-Inventor Count = 4.4

ph-index = 27

Forward Citations = 1,741(Granted Patents)

Inventors with similar research interests:

Location History:

Boston, MA (US) (2011 - 2015)
Concord, MA (US) (2013 - 2023)

Company Filing History:

Envivo Pharmaceuticals, Inc.

patents

8 out of 9

Forum Pharmaceuticals, Inc.

Eisai R&d Management Co., Ltd.

patents

6. 1 out of 230

Glaxosmithkline Intellectual Property Development Limited

patents

7. 1 out of 44

Ironwood Pharmaceuticals, Inc.

patents

8. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

107 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12168016 - Aryl-OR heteroaryl-substituted benzene compounds (2024-12-17),

2. 12168015 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-17),

3. 12161645 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-10),

4. 11834455 - Carm1 inhibitors and uses thereof (2023-12-05),

5. 11633420 - Method of treating leukemia (2023-04-25),

6. 11512053 - Arginine methyltransferase inhibitors and uses thereof (2022-11-29),

7. 11185531 - Arginine methyltransferase inhibitors and uses thereof (2021-11-30),

8. 11052093 - Aryl-or heteroaryl-substituted benzene compounds (2021-07-06),

9. 10980794 - PRMT5 inhibitors and uses thereof (2021-04-20),

10. 10881680 - Method of treating leukemia (2021-01-05),

11. 10800743 - Arginine methyltransferase inhibitors and uses thereof (2020-10-13),

12. 10669243 - Isoxazole carboxamides as irreversible SMYD inhibitors (2020-06-02),

13. 10653693 - PRMT5 inhibitors and uses thereof (2020-05-19),

14. 10633389 - CARM1 inhibitors and uses thereof (2020-04-28),

15. 10632103 - Arginine methyltransferase inhibitors and uses thereof (2020-04-28),

Title: Richard Chesworth: Pioneering Inventor Shaping the Future

Introduction:

Richard Chesworth, a visionary inventor based in Concord, MA, has dedicated his life to innovation and creating a positive impact on the world. With a total of 104 patents to his name, Chesworth's relentless pursuit of groundbreaking solutions has marked him as a true trailblazer in the field of technology.

Latest Patents:

Among his latest patents, "CARM1 inhibitors and uses thereof" stands out as a significant advancement in the medical field. These compounds are designed to inhibit CARM1 activity, offering promising avenues for treating CARM1-mediated disorders. Additionally, Chesworth's method for treating leukemia by administering DOT1L inhibitor compounds showcases his commitment to developing life-saving therapies.

Career Highlights:

Throughout his illustrious career, Chesworth has made significant contributions to companies such as Epizyme, Inc. and Envivo Pharmaceuticals, Inc. His expertise and innovative spirit have driven these organizations towards new frontiers in biotechnology and pharmaceuticals. Chesworth's strategic vision and inventive prowess have solidified his reputation as a pioneering inventor.

Collaborations:

Chesworth has collaborated with esteemed professionals in his field, including Gideon Shapiro and Kenneth William Duncan. Together, they have worked on groundbreaking projects, pushing the boundaries of technological innovation and medical research. These collaborations have not only enriched Chesworth's own work but have also inspired the next generation of inventors.

Conclusion:

In conclusion, Richard Chesworth's unwavering dedication to innovation and his passion for creating positive change have positioned him as a visionary inventor shaping the future of technology. His remarkable achievements in the realm of patents and inventions serve as a testament to his brilliance and his enduring legacy in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.